|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
26,320,000 |
Market
Cap: |
3.83(M) |
Last
Volume: |
169,426 |
Avg
Vol: |
168,958 |
52
Week Range: |
$0.1454 - $0.1454 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Witter Malcolm G |
Director |
|
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
143,888 |
|
- |
|
Cappello Alexander L |
Director |
|
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
46,477 |
|
- |
|
Bhalla Amit |
Director |
|
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
50,568 |
|
- |
|
Witter Malcolm G |
Director |
|
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
141,388 |
|
- |
|
Scott John K Jr. |
Director |
|
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
8,085,895 |
|
- |
|
Cappello Alexander L |
Director |
|
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
43,977 |
|
- |
|
Bhalla Amit |
Director |
|
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
48,068 |
|
- |
|
Rosol Michael Stanley |
Chief Medical Officer |
|
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,728 |
14,575 |
|
- |
|
Witter Malcolm G |
Director |
|
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
138,888 |
|
- |
|
Cappello Alexander L |
Director |
|
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
41,477 |
|
- |
|
Scott John K Jr. |
Director |
|
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
8,083,395 |
|
- |
|
Bhalla Amit |
Director |
|
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
45,568 |
|
- |
|
Witter Malcolm G |
Director |
|
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,995 |
102,252 |
|
- |
|
Cappello Alexander L |
Director |
|
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,762 |
3,762 |
|
- |
|
Bhalla Amit |
Director |
|
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,286 |
9,195 |
|
- |
|
Witter Malcolm G |
Director |
|
2021-09-17 |
4 |
B |
$1.60 |
$31,952 |
D/D |
20,000 |
98,257 |
2.39 |
- |
|
Witter Malcolm G |
Director |
|
2021-07-26 |
4 |
B |
$1.70 |
$25,470 |
D/D |
15,000 |
78,257 |
2.39 |
- |
|
Bruck Claudine |
Director |
|
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,969 |
16,519 |
|
- |
|
Witter Malcolm G |
Director |
|
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,757 |
63,257 |
|
- |
|
Bhalla Amit |
Director |
|
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,409 |
4,909 |
|
- |
|
Rouan Sarah Kathryn |
Director |
|
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,892 |
18,242 |
|
- |
|
Bhalla Amit |
Director |
|
2021-05-04 |
4 |
A |
$0.00 |
$3 |
D/D |
2,500 |
2,500 |
|
- |
|
Witter Malcolm G |
Director |
|
2021-04-23 |
4 |
B |
$1.60 |
$16,000 |
D/D |
10,000 |
57,000 |
2.39 |
- |
|
Witter Malcolm G |
Director |
|
2021-03-29 |
4 |
B |
$2.07 |
$44,505 |
D/D |
21,500 |
47,000 |
2.39 |
- |
|
Witter Malcolm G |
Director |
|
2021-03-03 |
4 |
B |
$2.31 |
$34,650 |
D/D |
15,000 |
25,500 |
2.39 |
- |
|
192 Records found
|
|
Page 3 of 8 |
|
|